ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $143M (100.0% shares, 0.0% debt)

Holdings (23)

PRAX PRAXIS PRECISION MEDICINES I 19.3%

Value $27.72M Shares 82,796 Est. Cost — Unrealized —

WHWK WHITEHAWK THERAPEUTICS INC 15.0%

Value $21.46M Shares 4,685,912 Est. Cost — Unrealized —

TNGX TANGO THERAPEUTICS INC 8.5%

Value $12.22M Shares 390,949 Est. Cost — Unrealized —

STRO SUTRO BIOPHARMA INC 6.3%

Value $8.972M Shares 270,251 Est. Cost — Unrealized —

AVBP ARRIVENT BIOPHARMA INC 5.3%

Value $7.597M Shares 218,694 Est. Cost — Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS INC 4.7%

Value $6.754M Shares 507,801 Est. Cost — Unrealized —

DRUG BRIGHT MINDS BIOSCIENCES INC 4.5%

Value $6.511M Shares 92,745 Est. Cost — Unrealized —

OCUL OCULAR THERAPEUTIX INC 3.6%

Value $5.229M Shares 532,481 Est. Cost — Unrealized —

ERAS ERASCA INC 3.4%

Value $4.858M Shares 265,199 Est. Cost — Unrealized —

SRZN SURROZEN INC 3.1%

Value $4.5M Shares 173,395 Est. Cost — Unrealized —

ARGX ARGEN SE - ADR 3.0%

Value $4.365M Shares 4,705 Est. Cost — Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 2.9%

Value $4.199M Shares 215,652 Est. Cost — Unrealized —

DSGN DESIGN THERAPEUTICS INC 2.8%

Value $4.089M Shares 282,564 Est. Cost — Unrealized —

NERV MINERVA NEUROSCIENCES 2.7%

Value $3.938M Shares 709,500 Est. Cost — Unrealized —

TSHA TAYSHA GENE THERAPIES INC 2.7%

Value $3.826M Shares 561,808 Est. Cost — Unrealized —

AVLN AVALYN PHARMA INC 2.6%

Value $3.786M Shares 115,000 Est. Cost — Unrealized —

AVTX AVALO THERAPEUTICS INC 2.4%

Value $3.443M Shares 186,308 Est. Cost — Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 2.1%

Value $3.019M Shares 168,115 Est. Cost — Unrealized —

ARTV ARTIVA BIOTHERAPEUTICS INC 1.8%

Value $2.526M Shares 260,416 Est. Cost — Unrealized —

CMPX COMPASS THERAPEUTICS INC 0.9%

Value $1.304M Shares 595,213 Est. Cost — Unrealized —

UTHR UNITED THERAPEUTICS CORP 0.8%

Value $1.205M Shares 2,224 Est. Cost — Unrealized —

CTNM CONTINEUM THERAPEUTICS INC-A 0.7%

Value $1.034M Shares 63,095 Est. Cost — Unrealized —

LBRX LB PHARMACEUTICALS INC 0.7%

Value $939K Shares 28,919 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PRAX	PRAXIS PRECISION MEDICINES I	82,796	$27.72M	19.3%	—	—	COM NEW	74006W207
WHWK	WHITEHAWK THERAPEUTICS INC	4,685,912	$21.46M	15.0%	—	—	COM	00032Q104
TNGX	TANGO THERAPEUTICS INC	390,949	$12.22M	8.5%	—	—	COM	87583X109
STRO	SUTRO BIOPHARMA INC	270,251	$8.972M	6.3%	—	—	COM	869367201
AVBP	ARRIVENT BIOPHARMA INC	218,694	$7.597M	5.3%	—	—	COM	04272N102
FDMT	4D MOLECULAR THERAPEUTICS INC	507,801	$6.754M	4.7%	—	—	COM	35104E100
DRUG	BRIGHT MINDS BIOSCIENCES INC	92,745	$6.511M	4.5%	—	—	COM NEW	10919W405
OCUL	OCULAR THERAPEUTIX INC	532,481	$5.229M	3.6%	—	—	COM	67576A100
ERAS	ERASCA INC	265,199	$4.858M	3.4%	—	—	COM	29479A108
SRZN	SURROZEN INC	173,395	$4.5M	3.1%	—	—	COM NEW	86889P208
ARGX	ARGEN SE - ADR	4,705	$4.365M	3.0%	—	—	SPONSORED ADR	04016X101
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	215,652	$4.199M	2.9%	—	—	CLASS ORD A	61559X104
DSGN	DESIGN THERAPEUTICS INC	282,564	$4.089M	2.8%	—	—	COM	25056L103
NERV	MINERVA NEUROSCIENCES	709,500	$3.938M	2.7%	—	—	COM NEW	603380205
TSHA	TAYSHA GENE THERAPIES INC	561,808	$3.826M	2.7%	—	—	COM SHS	877619106
AVLN	AVALYN PHARMA INC	115,000	$3.786M	2.6%	—	—	COM SHS	05348Y105
AVTX	AVALO THERAPEUTICS INC	186,308	$3.443M	2.4%	—	—	COM NEW	05338F306
AMLX	AMYLYX PHARMACEUTICALS INC	168,115	$3.019M	2.1%	—	—	COM	03237H101
ARTV	ARTIVA BIOTHERAPEUTICS INC	260,416	$2.526M	1.8%	—	—	COM	04317A107
CMPX	COMPASS THERAPEUTICS INC	595,213	$1.304M	0.9%	—	—	COM	20454B104
UTHR	UNITED THERAPEUTICS CORP	2,224	$1.205M	0.8%	—	—	COM	91307C102
CTNM	CONTINEUM THERAPEUTICS INC-A	63,095	$1.034M	0.7%	—	—	CL A	21217B100
LBRX	LB PHARMACEUTICALS INC	28,919	$939K	0.7%	—	—	COM SHS	50180M108